{"name":"Giovana Maria Weckwerth","slug":"giovana-maria-weckwerth","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Surgery with Naproxen","genericName":"Surgery with Naproxen","slug":"surgery-with-naproxen","indication":"Post-operative pain and inflammation management","status":"marketed"},{"name":"Surgery with Naproxen and Esomeprazole","genericName":"Surgery with Naproxen and Esomeprazole","slug":"surgery-with-naproxen-and-esomeprazole","indication":"Post-surgical pain and inflammation with gastroprotection","status":"marketed"}]}],"pipeline":[{"name":"Surgery with Naproxen","genericName":"Surgery with Naproxen","slug":"surgery-with-naproxen","phase":"marketed","mechanism":"Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.","indications":["Post-operative pain and inflammation management","Acute pain following surgical procedures"],"catalyst":""},{"name":"Surgery with Naproxen and Esomeprazole","genericName":"Surgery with Naproxen and Esomeprazole","slug":"surgery-with-naproxen-and-esomeprazole","phase":"marketed","mechanism":"Naproxen reduces post-surgical pain and inflammation via COX inhibition, while esomeprazole protects the gastrointestinal tract by suppressing gastric acid production.","indications":["Post-surgical pain and inflammation with gastroprotection"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}